(2018). Acetylcholinesterase inhibitors and the risk of osteoporotic fractures: nested case-control study. Osteoporos Int. http://doi.org/10.1007/s00198-017-4346-z
. I. Karp
First name
I.
Last name
Karp
(2019). Does the use of incretin-based medications increase the risk of cancer in patients with type-2 diabetes mellitus?. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4746
. (2021). Acetylcholinesterase inhibitors and risk of bleeding and acute ischemic events in non-hypertensive Alzheimer\textquoterights patients. Alzheimers Dement (N Y). http://doi.org/10.1002/trc2.12184
.